U.S. Residential REITs Stock News

CACI International (CACI) is back in focus after reporting record fiscal 2026 revenue, EBITDA margin, and free cash flow, along with fiscal 2027 guidance that points to continued double-digit revenue growth and strong cash generation. See our latest analysis for CACI International. CACI International's recent earnings release and contract wins appear to have shifted sentiment, with a 7 day share price return of 25.7% and a 30 day share price return of 32.5% pointing to strong near term...

HealthEquity stock has delivered a 61.0% return over the past 5 years, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to meaningful upside while earnings based multiples suggest the shares screen as expensive. Over the past 5 years, HealthEquity has returned 61.0%, which puts more focus on whether the current price still offers a margin of safety. Expectations around HealthEquity's ability to convert its revenue base...

Earlier this month, Replimune Group announced that the FDA granted accelerated approval for TUDRIQEV (vusolimogene oderparepvec-wtpg) in combination with nivolumab to treat adults with unresectable advanced cutaneous melanoma that has progressed after anti-PD-1 antibody-based therapy. This decision brings the first approved oncolytic HSV-1 viral therapy for this difficult-to-treat melanoma setting into clinical practice, anchored on objective response rate and duration of response from the...

Okta (OKTA) stock has drawn fresh attention after recent trading left shares at $148.32. Investors are weighing this move against the company’s latest financial profile and the wider performance of identity-focused software stocks. See our latest analysis for Okta. The latest move in Okta’s share price comes after a strong run, with a 90 day share price return of 87.60% and a 1 year total shareholder return of 67.57%. This indicates that momentum has been building rather than fading over...

Marvell Technology (NasdaqGS:MRVL) plans to invest US$250 million in India over the next three years to expand advanced semiconductor R&D. The company aims to double its India workforce and grow operations in Bangalore and Hyderabad focused on AI, cloud, and data infrastructure chips. Marvell also intends to build out an India based innovation network that links local engineering teams with global product development. This move shows that Marvell is only one part of a wider build out of AI...

Equitable Holdings earnings and buyback draw investor focus Equitable Holdings (EQH) is back in the spotlight after its second quarter 2026 earnings report showed weaker quarterly results alongside improved six month figures, paired with the completion of a multi billion dollar share repurchase program. See our latest analysis for Equitable Holdings. At a share price of US$51.52, Equitable Holdings has seen strong recent momentum, with a 30 day share price return of 9.62% and a 90 day share...

Structure Therapeutics (GPCR) drew investor attention after appointing John Berrios as Chief Commercial Officer and outlining upcoming aleniglipron clinical trial readouts across obesity, type 2 diabetes, body composition, and injectable-to-oral GLP-1 switching. See our latest analysis for Structure Therapeutics. The recent appointment and trial updates come against a mixed trading backdrop for Structure Therapeutics. The 90 day share price return of 40.43% and 1 year total shareholder return...

Duke Energy (DUK) is back in focus after reporting second quarter 2026 earnings and outlining a sizeable capital plan that includes a public offering of 35 million equity units tied to common stock and remarketable senior notes. See our latest analysis for Duke Energy. Duke Energy shares trade at US$124.85 and the stock has edged higher in the very short term, with a 1-day share price return of 0.77% and a year to date share price return of 6.31%. The 5 year total shareholder return of 39.18%...

Graham Corporation recently reported first-quarter fiscal 2027 results showing sales rising to US$71.34 million from US$55.49 million a year earlier, while net income eased to US$3.91 million and diluted EPS from continuing operations slipped to US$0.33. Award of over US$43 million in new and follow-on defense contracts for submarine and torpedo programs, alongside reaffirmed full-year fiscal 2027 sales guidance of US$285 million to US$295 million, underscores how defense work is becoming an...

Corporación América Airports (CAAP) is back on investors’ radar after recent share price moves that contrast with its longer term track record. The stock last closed at $25.08 on 4 August 2026. See our latest analysis for Corporación América Airports. Recent trading has been choppy for Corporación América Airports, with the share price down 4.06% over the last day and 5.61% so far this year. However, the 1 year total shareholder return of 18.47% and 5 year total shareholder return close to 4x...

Millicom International Cellular (TIGO) has drawn fresh attention after reporting its second quarter 2026 results and declaring an interim dividend of $1.50 per share, to be paid in two scheduled installments in early 2027. See our latest analysis for Millicom International Cellular. Millicom International Cellular's latest earnings announcement and interim dividend decision come after a sharp run in the stock, with the year to date share price return of 71.71% and a 1 year total shareholder...

Jackson Financial Inc. recently reported its second-quarter 2026 results, showing revenue of US$168 million versus very large revenue losses a year earlier, and net income rising to US$655 million, alongside announcing US$0.90 per-share common and US$0.50 preferred dividends plus continued execution of its multi-year share repurchase plan. With second-quarter basic earnings per share from continuing operations jumping to US$9.18 and cumulative buybacks now retiring 45.9% of shares since...

MercadoLibre's share price has declined over the past year even as its Discounted Cash Flow (DCF) intrinsic value estimate sits well above the current market price, which contrasts with earnings based multiples that point to a richer valuation. That split, along with a mixed value score, puts the focus on which lens investors should rely on when judging the stock today. Over the past 3 years the stock has returned about 40.4%, which suggests long term holders have still seen meaningful gains...

Why Trulieve Cannabis Earnings Matter For Investors Now Trulieve Cannabis (TRLV) reported second quarter 2026 results on 7 August that combined a larger net loss with lower sales, while still funding expansion in key medical cannabis markets. The company posted revenue of US$271 million for the quarter compared with US$302.1 million a year earlier, and reported a net loss of US$406 million versus US$13.8 million in the prior year period. See our latest analysis for Trulieve Cannabis. Trulieve...

Chimera Investment (CIM) reported a weaker first half of 2026, posting a net loss, while completing a multi year share repurchase program and signaling renewed interest in acquisitions. See our latest analysis for Chimera Investment. Chimera Investment's share price has eased in recent months, with a 30 day share price return of down 8.83% and a 90 day share price return of down 10.87%, even though the 1 year total shareholder return is positive at 2.09%. This softening coincides with weaker...

In late July 2026, Strategic Education, Inc. reported higher quarterly sales of US$337.26 million and net income of US$37.16 million, completed a long-running US$987.9 million share repurchase program covering 9,264,442 shares, and affirmed a regular quarterly dividend of US$0.60 per share. The combination of record employer enrollment, margin expansion, and ongoing cash returns via both buybacks and dividends highlights how the company is balancing growth investments with shareholder...

California Resources (CRC) drew fresh investor attention after reporting second quarter 2026 earnings, with revenue of US$1,297 million and net income of US$514 million, compared with US$978 million and US$172 million a year earlier. See our latest analysis for California Resources. Despite the strong second quarter results, California Resources’ recent share price has lost some momentum, with a 90 day share price return of 12.73% and a year to date share price return of 12.27%. However, the...

Markel Group stock has delivered a 47.2% gain over the past five years, yet current valuation checks suggest the shares now sit close to intrinsic value rather than offering a clear bargain or flashing a clear warning. Over five years Markel Group has returned 47.2%, which points to solid long term value creation for shareholders. Recent earnings strength and ongoing share repurchases can support the intrinsic value, while any setback in underwriting profitability or investment income...

In early August 2026, Yelp Inc. narrowed its fiscal 2026 net revenue guidance to a tighter US$1.46 billion to US$1.47 billion range, while also highlighting rapid adoption of its AI-powered restaurant tool, Yelp Host. The combination of more precise revenue guidance and over 1 million calls handled by Yelp Host underscores how AI-driven services are becoming a more central part of Yelp’s business model. Next, we’ll explore how Yelp’s tighter 2026 revenue outlook and growing Yelp Host...

Chevron (NYSE:CVX) has entered a 20 year Project Kilby energy supply agreement with Microsoft to support power needs for AI data centers. The deal positions Chevron as a dedicated energy partner to at least one major AI hyperscaler, focused on large scale, mission critical power infrastructure. Project Kilby is structured around Chevron's natural gas capabilities, with plans to integrate carbon capture and renewable power into the energy mix. Chevron aims to use this agreement as a template...

In early August 2026, BWX Technologies, Inc. reported higher second-quarter and first-half sales and net income, raised its full-year 2026 revenue outlook to approximately US$3.80 billion, and its board declared a quarterly dividend of US$0.27 per share payable on September 4, 2026. The company is also accelerating work on uranium centrifuge technology with the National Nuclear Security Administration, aiming to support a potential large U.S. enrichment buildout across multiple fuel grades...

Molson Coors Beverage (TAP) has come into focus after management outlined fresh acquisition plans alongside its second quarter 2026 results, pairing new deal ambitions with ongoing dividends and a sizable share repurchase program. See our latest analysis for Molson Coors Beverage. The latest acquisition talk and Q2 2026 earnings sit against a mixed share price picture for Molson Coors Beverage. The stock has a 1 month share price return of 10.72% and a 90 day share price return of 4.91%, yet...

In late July 2026, Essex Property Trust reported higher year-on-year second-quarter revenue but a sharp drop in net income, slightly lowered its full-year 2026 net income guidance, and completed a US$259.25 million buyback while authorizing a new US$500 million share repurchase program alongside ongoing acquisition plans. The combination of upgraded same-property revenue and core FFO guidance with an expanded buyback authorization highlights management’s emphasis on per-share value creation...

Iovance Biotherapeutics stock has delivered a striking 221.8% return over the past year, yet the latest valuation checks suggest the shares now look closer to fairly priced than clearly cheap. That mix of strong momentum and a mixed valuation read is what investors are trying to make sense of today. Iovance Biotherapeutics is up 221.8% over the last year, which puts recent buyers in a strong position and raises the bar for what needs to go right next. Strong recent revenue traction from its...